Table 1 Demographic parameters and co-morbidities according to treatment group
DPP4i | Metformin | Other oral | p Value | ||
|---|---|---|---|---|---|
n = 31 | n = 348 | n = 66 | |||
Demographics | |||||
Age (years) | 64.3 ± 9.7 | 67.3 ± 11.3 | 72.2 ± 12.9 | 0.001 | |
Male sex (%) | 84 | 71 | 70 | 0.30 | |
* | BMI (kg/m2) | 30.1 ± 4.4 | 28.4 ± 4.7 | 28.3 ± 3.6 | 0.04 |
Co-morbidities | |||||
† | Prior MI (%) | 41.9 | 37.7 | 48.5 | 0.25 |
‡ | Prior PCI (%) | 51.6 | 43.2 | 37.9 | 0.44 |
§ | Prior CHF (%) | 9.7 | 15.2 | 25.8 | 0.06 |
|| | Prior CRF (%) | 22.6 | 13.2 | 43.9 | <0.001 |
¶ | Prior PVD (%) | 16.1 | 10.7 | 25.0 | 0.007 |
Prior stroke (%) | 6.5 | 12.4 | 18.2 | 0.24 | |
Hypertension (%) | 83.9 | 81.8 | 90.9 | 0.20 | |
Dyslipidemia (%) | 87.1 | 88.1 | 80.0 | 0.21 | |
Smoker (%) | 20.0 | 26.2 | 19.7 | 0.45 | |
Admission laboratory parameters and values | |||||
* | Admission SBP (mmHg) | 150 ± 28 | 144 ± 29 | 144 ± 32 | 0.68 |
† | Admission DBP (mmHg) | 83 ± 16 | 81 ± 17 | 77 ± 16 | 0.13 |
Admission heart rate (bpm) | 80 ± 20 | 82 ± 19 | 85 ± 22 | 0.41 | |
‡ | Maximal CK (IU/L) | 121.5 (23–1994) | 167.0 (11–1994) | 218.0 (41–1808) | 0.20 |
Glucose (mg/dL) | 195 (111–429) | 159 (71–792) | 189 (40–506) | 0.09 | |
Leukocytes (cmm3x1000) | 10.4 ± 3.7 | 10.7 ± 4.3 | 10.9 ± 4.2 | 0.82 | |
§ | LDL-c (mg/dL) | 86 ± 27 | 90 ± 34 | 84 ± 30 | 0.58 |
Creatinine (mg/dL) | 1.0 (0.5–2.3) | 1.0 (0.5–7.6) | 1.4 (0.7–6.5) | <0.001 | |
Admission KILLIP >1 (%) | 9.7 | 16.4 | 34.8 | <0.001 | |